Terms: = Breast cancer AND NTRK1, ENSG00000198400, 4914, P04629, TRK1, MTC, DKFZp781I14186, p140-TrkA, TRKA, TRK AND Prognosis
35 results:
1. Risk factors for cervical lymph node metastasis in the central or lateral cervical region in medullary thyroid carcinoma: a systematic review and meta-analysis.
Lin X; Huo J; Su H; Zhu C; Xu Y; Zhang F
Eur Arch Otorhinolaryngol; 2024 Feb; 281(2):547-561. PubMed ID: 37801162
[TBL] [Abstract] [Full Text] [Related]
2. Preoperative identification of low-risk medullary thyroid carcinoma: potential application to reduce total thyroidectomy.
Park H; Ryu HJ; Heo J; Chung MK; Son YI; Kim JH; Hahn SY; Shin JH; Oh YL; Kim SW; Chung JH; Kim JS; Kim TH
Sci Rep; 2023 Sep; 13(1):15663. PubMed ID: 37730953
[TBL] [Abstract] [Full Text] [Related]
3. Ntrk gene aberrations in triple-negative breast cancer: detection challenges using IHC, FISH, RT-PCR, and NGS.
Zito Marino F; Buono S; Montella M; Giannatiempo R; Messina F; Casaretta G; Arpino G; Vita G; Fiorentino F; Insabato L; Sgambato A; Orditura M; Franco R; Accardo M
J Pathol Clin Res; 2023 Sep; 9(5):367-377. PubMed ID: 37143440
[TBL] [Abstract] [Full Text] [Related]
4. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
PeerJ; 2023; 11():e15025. PubMed ID: 36935920
[TBL] [Abstract] [Full Text] [Related]
5. Tumor Microenvironment in Male breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression.
Brcic I; Kluba AM; Godschachner TM; Suppan C; Regitnig P; Dandachi N; Lax SF; Balić M
Int J Mol Sci; 2023 Jan; 24(1):. PubMed ID: 36614261
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological features and genomic profiles of a group of secretory breast carcinomas in which progressive cases have more complex genomic features.
Lei T; Yang Y; Shi Y; Deng X; Peng Y; Wang H; Chen T
Diagn Pathol; 2022 Dec; 17(1):101. PubMed ID: 36585729
[TBL] [Abstract] [Full Text] [Related]
7. Expression and Signaling Pathways of Nerve Growth Factor (NGF) and Pro-NGF in breast cancer: A Systematic Review.
Bruno F; Arcuri D; Vozzo F; Malvaso A; Montesanto A; Maletta R
Curr Oncol; 2022 Oct; 29(11):8103-8120. PubMed ID: 36354700
[TBL] [Abstract] [Full Text] [Related]
8. Indoleamine 2,3-dioxygenase 2 immunohistochemical expression in medullary thyroid carcinoma: implications in prognosis and immunomodulatory effects.
Gu P; Ling B; Ma W; Zhang J; Zhang W; Zeng Y; Liu Y; Chi J; Ruan X; Zheng X; Wei S; Gao M
BMC Cancer; 2022 Nov; 22(1):1116. PubMed ID: 36319978
[TBL] [Abstract] [Full Text] [Related]
9. BDNF and its signaling in cancer.
Malekan M; Nezamabadi SS; Samami E; Mohebalizadeh M; Saghazadeh A; Rezaei N
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2621-2636. PubMed ID: 36173463
[TBL] [Abstract] [Full Text] [Related]
10. prognosis and oncogenomic profiling of patients with tropomyosin receptor kinase fusion cancer in the 100,000 genomes project.
Bridgewater J; Jiao X; Parimi M; Flach C; Stratford J; Kamburov A; Schmitz AA; Zong J; Reeves JA; Keating K; Bruno A; Fellous M; Pereira MB; Bazhenova L
Cancer Treat Res Commun; 2022; 33():100623. PubMed ID: 36041373
[TBL] [Abstract] [Full Text] [Related]
11. Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid cancer: Validating a Modified American Joint Committee on cancer Tumor-Node-Metastasis Staging System.
Wang Z; Tang C; Wang Y; Yin Z; Rixiati Y
Thyroid; 2022 May; 32(5):536-543. PubMed ID: 35350868
[No Abstract] [Full Text] [Related]
12. Genomic landscape of secretory carcinoma of the breast with axillary lymph node metastasis.
Chen M; Pu T; Wei B; Bu H; Tang P; Zhang Z
Pathol Res Pract; 2022 Mar; 231():153790. PubMed ID: 35158121
[TBL] [Abstract] [Full Text] [Related]
13. Pure and Mixed Tubular Carcinoma of the breast: Mammographic Features, Clinicopathological Characteristics and Prognostic Analysis.
Wen C; Xu W; Qin G; Zeng H; He Z; Wang S; Xu Z; Ma M; Luo Z; Chen W
Technol Cancer Res Treat; 2021; 20():15330338211045198. PubMed ID: 34918991
[No Abstract] [Full Text] [Related]
14. Reduced MHC class II expression in medullary thyroid cancer identifies patients with poor prognosis.
Ruan X; Yi J; Hu L; Zhi J; Zeng Y; Hou X; Huang J; Gu P; Hao W; Gao M; Pan Y; Wei S; Zheng X
Endocr Relat Cancer; 2022 Jan; 29(2):87-98. PubMed ID: 34874277
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic Value of Preoperative Serum Calcitonin Levels for Predicting the Recurrence of Medullary Thyroid Carcinoma.
Park H; Park SY; Park J; Choe JH; Chung MK; Woo SY; Choi JY; Kim SW; Chung JH; Kim TH
Front Endocrinol (Lausanne); 2021; 12():749973. PubMed ID: 34675884
[TBL] [Abstract] [Full Text] [Related]
16. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
[TBL] [Abstract] [Full Text] [Related]
17. miR‑592 acts as an oncogene and promotes medullary thyroid cancer tumorigenesis by targeting cyclin‑dependent kinase 8.
Liu T; Meng J; Zhang Y
Mol Med Rep; 2020 Oct; 22(4):3316-3326. PubMed ID: 32945439
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic Significance of Androgen Receptor Expression in Triple Negative breast cancer: A Systematic Review and Meta-Analysis.
Xu M; Yuan Y; Yan P; Jiang J; Ma P; Niu X; Ma S; Cai H; Yang K
Clin Breast Cancer; 2020 Aug; 20(4):e385-e396. PubMed ID: 32139270
[TBL] [Abstract] [Full Text] [Related]
19. Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid cancer and Medullary Thyroid cancer: A Multicenter, Open-Label, Phase II Trial.
Chen J; Ji Q; Bai C; Zheng X; Zhang Y; Shi F; Li X; Tang P; Xu Z; Huang R; Huang T; Pan Y; Fan S; Zhou J; Su W
Thyroid; 2020 Sep; 30(9):1245-1253. PubMed ID: 32075524
[No Abstract] [Full Text] [Related]
20. [Differential diagnostic value of the expression of the transcription factor PDX-1 in neuroendocrine and non-neuroendocrine tumors of the pancreas and other organs].
Gurevich LE; Proshchina AE; Voronkova IA; Ashevskaya VE; Korosteleva PA; Dolzhansky OV
Arkh Patol; 2019; 81(5):11-21. PubMed ID: 31626200
[TBL] [Abstract] [Full Text] [Related]
[Next]
